Welcome to LookChem.com Sign In|Join Free

CAS

  • or

6236-10-8

Post Buying Request

6236-10-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6236-10-8 Usage

Chemical Properties

white fine crystalline powder

Check Digit Verification of cas no

The CAS Registry Mumber 6236-10-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,2,3 and 6 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 6236-10:
(6*6)+(5*2)+(4*3)+(3*6)+(2*1)+(1*0)=78
78 % 10 = 8
So 6236-10-8 is a valid CAS Registry Number.
InChI:InChI=1/C5H8O5/c1-5(10,4(8)9)2-3(6)7/h10H,2H2,1H3,(H,6,7)(H,8,9)/t5-/m1/s1

6236-10-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name D-(-)-Citramalic Acid

1.2 Other means of identification

Product number -
Other names (2R)-2-hydroxy-2-methylbutanedioic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6236-10-8 SDS

6236-10-8Synthetic route

((3R,8aS)-3-Methyl-1,4-dioxo-hexahydro-pyrrolo[2,1-c][1,4]oxazin-3-yl)-acetic acid ethyl ester
205579-47-1

((3R,8aS)-3-Methyl-1,4-dioxo-hexahydro-pyrrolo[2,1-c][1,4]oxazin-3-yl)-acetic acid ethyl ester

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

Conditions
ConditionsYield
With hydrogenchloride for 5h; Heating;100%
(S)-4-methyl-4-(trichloromethyl)-2-oxetanone
93206-60-1

(S)-4-methyl-4-(trichloromethyl)-2-oxetanone

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

Conditions
ConditionsYield
With sodium hydroxide at 20℃; for 18h; Hydrolysis;91%
With sodium hydroxide In water 1.) 5 deg C; 2.) room temperature;
trans-2-phenylcyclohexyl citramalate
119696-04-7

trans-2-phenylcyclohexyl citramalate

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

Conditions
ConditionsYield
With potassium hydroxide In tetrahydrofuran at 60℃; for 24h;87%
2-hydroxy-2-methylbutane-1,4-dioic acid
597-44-4

2-hydroxy-2-methylbutane-1,4-dioic acid

A

L-malic acid
2174-58-5

L-malic acid

B

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

Conditions
ConditionsYield
With formaldehyd; TETRACYCLINE; paraquat dichloride In water at 37℃; for 69h; Clostridium formicoaceticum, phosphate buffer;A 84.8%
B 81.8%
(R)-3-cyano-2-hydroxy-2-methylpropanamide

(R)-3-cyano-2-hydroxy-2-methylpropanamide

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

Conditions
ConditionsYield
With barium dihydroxide; water for 48h; Heating;81%
(-)-Isotetradehydrofurospongin-1

(-)-Isotetradehydrofurospongin-1

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

Conditions
ConditionsYield
Stage #1: (-)-Isotetradehydrofurospongin-1 With ozone In dichloromethane at -78℃;
Stage #2: With jones reagent In dichloromethane at 20℃; Further stages.;
25%
2-hydroxy-2-methylbutane-1,4-dioic acid
597-44-4

2-hydroxy-2-methylbutane-1,4-dioic acid

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

Conditions
ConditionsYield
With brucine
citraconic acid
498-23-7

citraconic acid

A

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

B

(2R,3S)-3-methylmalic acid
152204-30-3

(2R,3S)-3-methylmalic acid

Conditions
ConditionsYield
With TETRACYCLINE In water at 37℃; for 142h; Clostridium formicoaceticum, phosphate buffer; Title compound not separated from byproducts;
1-benzyl hydrogen 2-hydroxy-2-methylbutanedioate

1-benzyl hydrogen 2-hydroxy-2-methylbutanedioate

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

Conditions
ConditionsYield
With potassium hydroxide Hydrolysis;
14-O-α-L-rhamnopyranosyl-(2E,4E,7R,8E,10E,12E,14R)-7,9,13,17-tetramethyl-7,14-dihydroxy-2,4,8,10,12,16-octadecahexaenoic acid

14-O-α-L-rhamnopyranosyl-(2E,4E,7R,8E,10E,12E,14R)-7,9,13,17-tetramethyl-7,14-dihydroxy-2,4,8,10,12,16-octadecahexaenoic acid

A

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

B

oxalic acid
144-62-7

oxalic acid

C

acetic acid
64-19-7

acetic acid

D

2-oxo-propionic acid
127-17-3

2-oxo-propionic acid

Conditions
ConditionsYield
With ozone In dichloromethane at -78℃; for 0.0833333h; Further byproducts given. Title compound not separated from byproducts;
14-O-α-L-rhamnopyranosyl-(2E,4E,7R,8E,10E,12E,14R)-7,9,13,17-tetramethyl-7,14-dihydroxy-2,4,8,10,12,16-octadecahexaenoic acid

14-O-α-L-rhamnopyranosyl-(2E,4E,7R,8E,10E,12E,14R)-7,9,13,17-tetramethyl-7,14-dihydroxy-2,4,8,10,12,16-octadecahexaenoic acid

A

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

B

malonic acid
141-82-2

malonic acid

C

acetic acid
64-19-7

acetic acid

D

2-oxo-propionic acid
127-17-3

2-oxo-propionic acid

Conditions
ConditionsYield
With ozone In dichloromethane at -78℃; for 0.0833333h; Further byproducts given. Title compound not separated from byproducts;
14-O-α-D-mannopyranosyl-(2E,4E,7R,8E,10E,12E,14S)-7,9,13,17-tetramethyl-7,14-dihydroxy-2,4,8,10,12,16-octadecahexaenoic acid

14-O-α-D-mannopyranosyl-(2E,4E,7R,8E,10E,12E,14S)-7,9,13,17-tetramethyl-7,14-dihydroxy-2,4,8,10,12,16-octadecahexaenoic acid

A

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

B

oxalic acid
144-62-7

oxalic acid

C

acetic acid
64-19-7

acetic acid

D

2-oxo-propionic acid
127-17-3

2-oxo-propionic acid

Conditions
ConditionsYield
With ozone In dichloromethane at -78℃; for 0.0833333h; Further byproducts given. Title compound not separated from byproducts;
14-O-α-D-mannopyranosyl-(2E,4E,7R,8E,10E,12E,14S)-7,9,13,17-tetramethyl-7,14-dihydroxy-2,4,8,10,12,16-octadecahexaenoic acid

14-O-α-D-mannopyranosyl-(2E,4E,7R,8E,10E,12E,14S)-7,9,13,17-tetramethyl-7,14-dihydroxy-2,4,8,10,12,16-octadecahexaenoic acid

A

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

B

malonic acid
141-82-2

malonic acid

C

acetic acid
64-19-7

acetic acid

D

2-oxo-propionic acid
127-17-3

2-oxo-propionic acid

Conditions
ConditionsYield
With ozone In dichloromethane at -78℃; for 0.0833333h; Further byproducts given. Title compound not separated from byproducts;
2-methyl-2-butenedioic acid 4-ethylester
66261-38-9

2-methyl-2-butenedioic acid 4-ethylester

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 100 percent / diethyl phosphorocyanidate, TEA / dimethylformamide / 2 h / 0 °C
2: 98 percent / trifluoroacetic acid / CH2Cl2 / 3 h / Ambient temperature
3: 83 percent / N-iodosuccinimide / dimethylformamide / 12 h / 36 °C
4: 92 percent / n-Bu3SnH / benzene / 0.5 h / Heating
5: 100 percent / 6N aq. HCl / 5 h / Heating
View Scheme
ethyl (E)-4-hydroxy-3-methyl-2-butenoate
65527-85-7

ethyl (E)-4-hydroxy-3-methyl-2-butenoate

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 96 percent / CrO3, 1.5 M H2SO4 / acetone
2: 100 percent / diethyl phosphorocyanidate, TEA / dimethylformamide / 2 h / 0 °C
3: 98 percent / trifluoroacetic acid / CH2Cl2 / 3 h / Ambient temperature
4: 83 percent / N-iodosuccinimide / dimethylformamide / 12 h / 36 °C
5: 92 percent / n-Bu3SnH / benzene / 0.5 h / Heating
6: 100 percent / 6N aq. HCl / 5 h / Heating
View Scheme
(E)-4-(tert-butyldimethylsilanyloxy)-3-methylbut-2-enoic acid ethyl ester
132032-94-1

(E)-4-(tert-butyldimethylsilanyloxy)-3-methylbut-2-enoic acid ethyl ester

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 97 percent / tetrabutylammonium fluoride / tetrahydrofuran
2: 96 percent / CrO3, 1.5 M H2SO4 / acetone
3: 100 percent / diethyl phosphorocyanidate, TEA / dimethylformamide / 2 h / 0 °C
4: 98 percent / trifluoroacetic acid / CH2Cl2 / 3 h / Ambient temperature
5: 83 percent / N-iodosuccinimide / dimethylformamide / 12 h / 36 °C
6: 92 percent / n-Bu3SnH / benzene / 0.5 h / Heating
7: 100 percent / 6N aq. HCl / 5 h / Heating
View Scheme
(S)-1-((E)-3-Ethoxycarbonyl-2-methyl-acryloyl)-pyrrolidine-2-carboxylic acid
205579-44-8

(S)-1-((E)-3-Ethoxycarbonyl-2-methyl-acryloyl)-pyrrolidine-2-carboxylic acid

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 83 percent / N-iodosuccinimide / dimethylformamide / 12 h / 36 °C
2: 92 percent / n-Bu3SnH / benzene / 0.5 h / Heating
3: 100 percent / 6N aq. HCl / 5 h / Heating
View Scheme
(S)-Iodo-((3S,8aS)-3-methyl-1,4-dioxo-hexahydro-pyrrolo[2,1-c][1,4]oxazin-3-yl)-acetic acid ethyl ester
205579-46-0

(S)-Iodo-((3S,8aS)-3-methyl-1,4-dioxo-hexahydro-pyrrolo[2,1-c][1,4]oxazin-3-yl)-acetic acid ethyl ester

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 92 percent / n-Bu3SnH / benzene / 0.5 h / Heating
2: 100 percent / 6N aq. HCl / 5 h / Heating
View Scheme
(S)-1-((E)-3-Ethoxycarbonyl-2-methyl-acryloyl)-pyrrolidine-2-carboxylic acid tert-butyl ester
205579-42-6

(S)-1-((E)-3-Ethoxycarbonyl-2-methyl-acryloyl)-pyrrolidine-2-carboxylic acid tert-butyl ester

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 98 percent / trifluoroacetic acid / CH2Cl2 / 3 h / Ambient temperature
2: 83 percent / N-iodosuccinimide / dimethylformamide / 12 h / 36 °C
3: 92 percent / n-Bu3SnH / benzene / 0.5 h / Heating
4: 100 percent / 6N aq. HCl / 5 h / Heating
View Scheme
(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

(R)-dimethyl 2-hydroxy-2-methylsuccinate
81426-68-8

(R)-dimethyl 2-hydroxy-2-methylsuccinate

Conditions
ConditionsYield
In methanol100%
In diethyl ether at 0℃; for 2h;90%
In methanol; diethyl ether at 0℃;
(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

(S)-(-)-2-Methylbutane-1,2,4-triol
60299-29-8

(S)-(-)-2-Methylbutane-1,2,4-triol

Conditions
ConditionsYield
With borane-THF In tetrahydrofuran at 0℃; Reflux;100%
methanol
67-56-1

methanol

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

(R)-dimethyl 2-hydroxy-2-methylsuccinate
81426-68-8

(R)-dimethyl 2-hydroxy-2-methylsuccinate

Conditions
ConditionsYield
Stage #1: (R)-(-)-citramalic acid With thionyl chloride In methanol; dichloromethane at 0 - 20℃; Inert atmosphere;
Stage #2: methanol In dichloromethane at 0 - 20℃; Inert atmosphere;
97.3%
With hydrogenchloride at 55℃; for 48h;72%
With hydrogenchloride Esterification;
With thionyl chloride
(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

benzyl bromide
100-39-0

benzyl bromide

1-benzyl 4-benzyl 2-hydroxy-2-methylbutanedioate
1115955-01-5

1-benzyl 4-benzyl 2-hydroxy-2-methylbutanedioate

Conditions
ConditionsYield
With caesium carbonate In N,N-dimethyl-formamide at 20℃;90%
(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

poly(methacrylic acid)
79-41-4

poly(methacrylic acid)

Conditions
ConditionsYield
sodium hydroxide In water at 300℃; under 262201 Torr; Product distribution / selectivity;80.8%
(Et4N)2{MoFe3S4Cl3(Cl4cat)(CH3CN)}

(Et4N)2{MoFe3S4Cl3(Cl4cat)(CH3CN)}

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

(Et4N)3[(MoFe3S4Cl3)(R-citramalate(1-))] * 0.50 MeCN

(Et4N)3[(MoFe3S4Cl3)(R-citramalate(1-))] * 0.50 MeCN

Conditions
ConditionsYield
In acetonitrile absence of air; treatment of Mo-complex with 1.5 fold excess of citramalic acid, stirring (50°C, 24 h); cooling to room temp., filtration, pptn. on Et2O addn. to filtrate, recrystn. (MeCN/Et2O), washing (MeOH, Me2CO, Et2O), drying (vac.); elem. anal.;65%
tetraethylammonium hydroxide

tetraethylammonium hydroxide

tricarbonyl(cycloheptatriene)molybdenum(0)
12125-77-8

tricarbonyl(cycloheptatriene)molybdenum(0)

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

[Et4N]2[((R)-(+)-citramallic acid(-2H))Mo(CO)3]

[Et4N]2[((R)-(+)-citramallic acid(-2H))Mo(CO)3]

Conditions
ConditionsYield
In methanol (N2); Schlenk technique; soln. of Et4OH in methanol was added to soln. of acid in methanol; mixt. was dried (vac.); redissolved in methanol; obtained soln. was added to soln. of Mo complex in methanol at room temp.; soln. was stirred overnight; evapd.; extd. (MeCN/MeOH); layered with ether; elem. anal.;63%
(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

Hexafluoroacetone
684-16-2

Hexafluoroacetone

[(5R)-2,2-Bis(trifluoromethyl)-5-methyl-4-oxo-1,3-dioxolan-5-yl] acetic acid
276257-67-1

[(5R)-2,2-Bis(trifluoromethyl)-5-methyl-4-oxo-1,3-dioxolan-5-yl] acetic acid

Conditions
ConditionsYield
In dimethyl sulfoxide at 20℃; Cyclization;61%
4,4'-bipyridine
553-26-4

4,4'-bipyridine

uranyl nirate hexahydrate

uranyl nirate hexahydrate

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

[H2-4,4'-bipy][UO2(citml)(H2O)]2*H2O

[H2-4,4'-bipy][UO2(citml)(H2O)]2*H2O

Conditions
ConditionsYield
In water High Pressure; D-(-)-citramalic acid, UO2(NO3)2*6H2O, 4,4'-bipyridine, and water in closed vessel were heated at 140°C for 2 days; elem. anal.;52%
1,4-diaza-bicyclo[2.2.2]octane
280-57-9

1,4-diaza-bicyclo[2.2.2]octane

uranyl nirate hexahydrate

uranyl nirate hexahydrate

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

[H2DABCO][UO2(citml)]2

[H2DABCO][UO2(citml)]2

Conditions
ConditionsYield
In water High Pressure; D-(-)-citramalic acid, UO2(NO3)2*6H2O, DABCO, and water in closed vesselwere heated at 140°C for 24 h; elem. anal.;40%
[2,2]bipyridinyl
366-18-7

[2,2]bipyridinyl

uranyl nirate hexahydrate

uranyl nirate hexahydrate

cadmium(II) nitrate tetrhydrate

cadmium(II) nitrate tetrhydrate

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

2C5H5O5(3-)*Cd(2+)*C10H8N2*2H2O*2O2U(2+)

2C5H5O5(3-)*Cd(2+)*C10H8N2*2H2O*2O2U(2+)

Conditions
ConditionsYield
In water; acetonitrile at 140℃; Sealed tube;33%
1,10-Phenanthroline
66-71-7

1,10-Phenanthroline

uranyl nirate hexahydrate

uranyl nirate hexahydrate

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

[H-1,10-phenanthroline]2[(UO2)5(D-(-)-citramalic acid)4(H2O)]*3H2O

[H-1,10-phenanthroline]2[(UO2)5(D-(-)-citramalic acid)4(H2O)]*3H2O

Conditions
ConditionsYield
In water at 180℃; for 48h;32%
(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

C20H23F2N3O2*(x)ClH

C20H23F2N3O2*(x)ClH

(R)-4-(3-((2-(difluoromethoxy)-6-methylpyridin-3-yl)carbamoyl)-3-(2-isopropylphenyl)azetidin-1-yl)-2-hydroxy-2-methyl-4-oxobutanoic acid

(R)-4-(3-((2-(difluoromethoxy)-6-methylpyridin-3-yl)carbamoyl)-3-(2-isopropylphenyl)azetidin-1-yl)-2-hydroxy-2-methyl-4-oxobutanoic acid

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 1h; Inert atmosphere;24%
(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

(R)-4-(2-Benzenesulfonyl-ethyl)-2,2,4-trimethyl-[1,3]dioxolane
80320-89-4

(R)-4-(2-Benzenesulfonyl-ethyl)-2,2,4-trimethyl-[1,3]dioxolane

Conditions
ConditionsYield
Multistep reaction;
(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

(R)-(+)-2-Methylbutane-1,2,4-triol
81426-65-5

(R)-(+)-2-Methylbutane-1,2,4-triol

Conditions
ConditionsYield
With dimethylsulfide borane complex In tetrahydrofuran; methanol
Multi-step reaction with 2 steps
1: 10.02 g / CH2Cl2; ethanol / 0.5 h
2: 84 percent / LiAlH4 / tetrahydrofuran / 18 h / Heating
View Scheme
bromal
115-17-3

bromal

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

[(4R)-4-methyl-5-oxo-2-(tribromomethyl)-1,3-dioxolan-4-yl]acetic acid

[(4R)-4-methyl-5-oxo-2-(tribromomethyl)-1,3-dioxolan-4-yl]acetic acid

Conditions
ConditionsYield
With sulfuric acid; acetic acid at 0℃; for 2h;
ethanol
64-17-5

ethanol

(R)-(-)-citramalic acid
6236-10-8

(R)-(-)-citramalic acid

diethyl (2R)-2-hydroxy-2-methylsuccinate
681236-46-4

diethyl (2R)-2-hydroxy-2-methylsuccinate

Conditions
ConditionsYield
With toluene-4-sulfonic acid In benzene for 72h; Heating;

6236-10-8Relevant articles and documents

Regio- and stereocontrolled hydrocyanation of chiral 2-alkylglycidamides with Et2AlCN: Synthesis of enantiomerically pure mono- and disubstituted malic acid derivatives

Garcia Ruano, Jose L.,Fernandez-Ibaez,Martin Castro, Ana M.,Rodriguez Ramos, Jesus H.,Rubio Flamarique, Ana C.

, p. 1321 - 1325 (2007/10/03)

The opening of the oxirane ring of glycidamides with Et2AlCN takes place under mild conditions in a completely regio- and stereoselective manner to afford β-cyano carboxamide derivatives, which are immediate precursors of mono- and disubstituted malic acid derivatives. The complete control of the regioselectivity can be rationalized as a consequence of the association of the reagent with the carboxamide group prior to intramolecular cyanide transfer.

Structure revision and assignment of absolute stereochemistry of a marine C21 bisfuranoterpene

Capon, Robert J.,Jenkins, Alister,Rooney, Francis,Ghisalberti, Emilio L.

, p. 638 - 639 (2007/10/03)

The C21 bisfuranoterpene (-)-isotetradehydrofurospongin-1 (6), previously isolated from a Western Australian Spongia sp., has been reisolated from a specimen of Spirastrella papilosa collected during scientific trawling operations in the Great Australian Bight. A 2D NMR analysis of 6 has prompted reassignment of the published structure 5, while degradation and chiral HPLC analysis have allowed determination of the absolute stereochemistry.

Asymmetric synthesis of (R)(-)-dimethyl citramalate

Jew, Sang-Sup,Kim, Hyun-Ah,Song, Sam-Mi,Jang, Jung-Sook,Park, Hyeung-Geun

, p. 153 - 156 (2007/10/03)

An asymmetric synthesis of (R)(-)-dimethyl citramalate (1), involving halolactonization by using (S)(-)-proline as a chiral auxiliary, is reported.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6236-10-8